About this trial
This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
aged 18 and above, reside in Zhuhai for the next 6 months
smoke at least 1 cigarette or use e-cigarettes daily
have a smartphone and a WeChat account, able to use WeChat skillfully
Disqualifiers
Smokers who have communication barrier (either physically or cognitively)
Smokers who are currently participating in other SC programmes or services
Trial design
Parallel
Treatments tested in this trial
5A's/5R's advice
Behavioral5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.
Health warning leaflet
Other interventionThe health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.
AI-powered chatbot support
BehavioralParticipants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.
Treatment groups
Trial outcomes
Primary outcomes
Self-reported 7-day point prevalence quit rate
Self-reported 7-day point prevalence quit rate in the two groups
Eligibility rate
the percentage of eligible smokers out of the total number of smokers screened
Secondary outcomes
Consent rate
the percentage of eligible smokers who agree to participate out of the total number of eligible smokers
Percentage of Participant Engagement with E-Messages and Counselor Chats
This outcome measures the percentage of participants who engage with the intervention by reading e-messages and responding to counselor chat messages at least once during the 3-month follow-up period.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.